Gene Lay - Business-News-Today.com

PerkinElmer to acquire antibodies and reagents manufacturer BioLegend

pallavi123 - July 26, 2021 0

PerkinElmer has signed a cash and stock deal worth around $5.25 billion to acquire BioLegend, a California-based antibodies and reagents manufacturer. BioLegend caters to academic ... Read More

PerkinElmer to acquire antibodies and reagents manufacturer BioLegend

Hyatt and Grupo Piñero partner to expand all-inclusive portfolio

Southern Glazer’s expands U.S. footprint with Horizon Beverage Group acquisition

Walker & Dunlop secures $245m financing for Jersey City’s The Greyson development

Stages of development of the human fetus: A comprehensive overview

Understanding alcohol abuse: What it means for your health

Adani Ports strengthens maritime fleet with Rs 450cr ‘Make in India’ deal

Was Azerbaijan Airlines flight taken down by a missile?

Tourist bus plunges into icy Norway lake, leaving three dead

The visionary legacy of Manmohan Singh: India’s architect of economic transformation

ACME Solar secures Rs 1,988cr financing and expands renewable portfolio with 300MW SECI Project

Rose Merc expands into GCC market with strategic stake in Emirates Holding FZ

Teck Resources and Dreadnought Resources forge strategic alliance for Bresnahan exploration

DoubleU Games acquires Paxie Games to expand into thriving Merge-2 market

WiSA Technologies announces definitive agreement to acquire CompuSystems

HelloFresh launches new year-ready offerings for effortless, nutritious home cooking

Aayush Wellness embarks on strategic expansion into wellness tourism

Royal Orchid Hotels launches Regenta Evolife Dome City for Mahakumbh 2025

Healthy Life Agritec Expands Operations with new Bangalore manufacturing facility

Calangute beach boat capsize: One dead, dozens rescued in dramatic lifesaving effort

Massive missile strikes plunge Ukraine into Christmas blackouts amid escalating conflict